PC
GEVA

Polar Capital’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Polar Capital’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-6,881
Closed -$671K – 320
2015
Q1 		$671K Sell
6,881
-3,403
-33% -$360K 0.01% 260
2014
Q4 		$954K Buy
+10,284
New +$812K 0.02% 241

Polar Capital's GEVA Position: Q2 2015 in Review

Polar Capital sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 6,881 shares — an estimated $671K sold.

Polar Capital first reported a position in GEVA in Q4 2014 and held it in 2 quarters. The position peaked at $954K in Q4 2014. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • Polar Capital reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Polar Capital sold 6,881 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $671K.
  • Polar Capital first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q4 2014 and held it in 2 quarters.
  • Polar Capital's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $954K in Q4 2014.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Polar Capital's 13F filing for Q2 2015, filed 14 Aug 2015.